
Quest Diagnostics (DGX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Quest Diagnostics (DGX) last issued guidance on July 23, 2026 for fiscal year 2026. The company guided earnings per share in the range of $11.05 - $11.25, compared to a consensus EPS estimate of $10.76. Quest Diagnostics also guided revenue in the range of $11.95B - $12.05B for the period.
Compared to prior guidance, Quest Diagnostics raised its EPS outlook from a previous range of $10.63 - $10.83. On the revenue side, the company raised its revenue forecast from a prior range of $11.78B - $11.9B.
Quest Diagnostics has issued 18 guidance updates between October 20, 2022 and July 23, 2026. During this period, the company raised its outlook 6 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.82 | $2.36 | $2.35 | $2.51 |
| Actual | $3.12 | $2.50 | $2.42 | $2.60 |
| Surprise | +10.6% | +5.93% | +2.98% | +3.59% |
| Revenue | ||||
| Estimate | $2.97B | $2.82B | $2.76B | $2.73B |
| Actual | $3.04B | $2.90B | $2.81B | $2.82B |
| Surprise | +2.29% | +2.63% | +1.76% | +3.19% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.87 | $2.68 | $2.76 | $3.16 |
| Revenue | ||||
| Consensus | $3.05B | $3.02B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 23, 2026 | $3.12 | $2.82 | 10.6 % |
| Q1 | Apr 21, 2026 | $2.50 | $2.36 | 5.93 % |
| Q4 | Feb 10, 2026 | $2.42 | $2.35 | 2.98 % |
| Q3 | Oct 21, 2025 | $2.60 | $2.51 | 3.59 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 23, 2026 | $3.04B | $2.97B | 2.29 % |
| Q1 | Apr 21, 2026 | $2.90B | $2.82B | 2.63 % |
| Q4 | Feb 10, 2026 | $2.81B | $2.76B | 1.76 % |
| Q3 | Oct 21, 2025 | $2.82B | $2.73B | 3.19 % |